{"id":13251,"date":"2025-07-03T00:06:00","date_gmt":"2025-07-03T00:06:00","guid":{"rendered":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/"},"modified":"2025-07-03T00:06:00","modified_gmt":"2025-07-03T00:06:00","slug":"%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8","status":"publish","type":"post","link":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/","title":{"rendered":"\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f"},"content":{"rendered":"

\u8212\u6c83\u54f2\u00ae\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\uff0c\u6210\u4e3a\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u5728\u7f8e\u56fd\u83b7\u6279\u7684\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC<\/span>\uff09\u56fd\u521b\u65b0\u836f\uff0c\u540c\u65f6\u4e5f\u662f\u4e2d\u56fd\u9996\u4e2a\u72ec\u7acb\u7814\u53d1\u5728\u7f8e\u83b7\u6279\u7684\u5168\u7403\u9996\u521b\u65b0\u836f<\/span>\u6b64\u6b21\u52a0\u901f\u6279\u51c6\u57fa\u4e8e\u56fd\u9645\u591a\u4e2d\u5fc3\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\uff08\u609f\u7a7a1B,WU-KONG1B\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u5c55\u73b0\u8212\u6c83\u54f2\u00ae\u9488\u5bf9\u7ecf\u6cbbEGFR exon20ins NSCLC\u5168\u7403\u540c\u7c7b\u6700\u4f73\uff08Best-in-Class\uff09\u6f5c\u529b<\/span><\/p>\n

\u4e0a\u6d77<\/span>2025\u5e747\u67083\u65e5<\/span> \/\u7f8e\u901a\u793e\/ — \u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u5ba3\u5e03\uff0c\u8212\u6c83\u54f2\u00ae\uff08ZEGFROVY\u00ae\uff0c\u901a\u7528\u540d\uff1a\u8212\u6c83\u66ff\u5c3c\u7247\uff09\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Application\uff0cNDA\uff09\uff0c\u6b63\u5f0f\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\uff0c\u7528\u4e8e\u65e2\u5f80\u7ecf\u542b\u94c2\u5316\u7597\u6cbb\u7597\u65f6\u6216\u6cbb\u7597\u540e\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u5e76\u4e14\u7ecfFDA\u6279\u51c6\u7684\u8bd5\u5242\u76d2\u68c0\u6d4b\u786e\u8ba4\uff0c\u5b58\u5728\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u7684\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u7684\u6210\u4eba\u60a3\u8005\u3002<\/p>\n

\n

\n <\/a><\/p>\n

\n <\/p>\n<\/div>\n

\u8212\u6c83\u54f2\u00ae\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\u83b7\u5f97\u6279\u51c6\u4e0a\u5e02\uff0c\u6210\u4e3a\u76ee\u524d\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins NSCLC\u56fd\u521b\u65b0\u836f\u3002\u5176\u5728\u5206\u5b50\u8bbe\u8ba1\u7684\u6e90\u5934\u8fdb\u884c\u4e86\u91cd\u5927\u521b\u65b0\uff0c\u7a81\u7834\u96be\u6cbb\u9776\u70b9\uff0c\u662f\u4e2d\u56fd\u9996\u4e2a\u72ec\u7acb\u7814\u53d1\u5728\u7f8e\u83b7\u6279\u7684\u5168\u7403\u9996\u521b\u65b0\u836f\u3002<\/span><\/p>\n

\u8fea\u54f2\u533b\u836f\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5f20\u5c0f\u6797\u535a\u58eb\u8868\u793a\uff1a”\u4f5c\u4e3a\u516c\u53f8\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684\u521b\u65b0\u836f<\/span>\uff0c\u8212\u6c83\u54f2\u00ae\u7684\u52a0\u901f\u83b7\u6279\u4e0d\u4ec5\u4e3a\u5168\u7403EGFR 20\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u5e26\u6765\u5168\u65b0\u6cbb\u7597\u65b9\u6848\uff0c\u66f4\u4ee5\u4e2d\u56fd\u6e90\u5934\u521b\u65b0\u8fc8\u51fa\u2018\u79d1\u6280\u521b\u65b0\u5f15\u9886\u5168\u7403’\u5f81\u7a0b\u4e0a\u7684\u65b0\u8de8\u8d8a\u3002\u8212\u6c83\u54f2\u00ae\u662f\u76ee\u524d\u5168\u7403\u552f\u4e00\u83b7\u6279\u6cbb\u7597EGFR exon20ins NSCLC\u7684\u53e3\u670d\u5c0f\u5206\u5b50\u9776\u5411\u836f\uff0c\u5177\u5907\u7597\u6548\u3001\u5b89\u5168\u6027\u53ca\u4fbf\u5229\u6027\u5168\u7403\u540c\u7c7b\u6700\u4f73\u7684\u6f5c\u5728\u4f18\u52bf\u3002\u8fd9\u4e00\u5728\u7f8e\u83b7\u6279\u7684\u91cc\u7a0b\u7891\u4e8b\u4ef6\uff0c\u8fdb\u4e00\u6b65\u575a\u5b9a\u4e86\u8fea\u54f2\u533b\u836f\u81f4\u529b\u4e8e\u4ee5\u7a81\u7834\u6027\u521b\u65b0\u7597\u6cd5\u586b\u8865\u5168\u7403\u672a\u88ab\u6ee1\u8db3\u4e34\u5e8a\u9700\u6c42\u7684\u6218\u7565\u51b3\u5fc3\u3002”<\/p>\n

\u8212\u6c83\u54f2\u00ae\u662f\u4e00\u6b3e\u53e3\u670d\u3001\u4e0d\u53ef\u9006\u4e14\u9488\u5bf9\u591a\u79cdEGFR\u7a81\u53d8\u4e9a\u578b\u7684\u9ad8\u9009\u62e9\u6027EGFR\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\uff0c\u4e8e2023\u5e748\u6708\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\uff0c\u586b\u8865\u4e86\u8be5\u9886\u57df\u8fd120\u5e74\u4e34\u5e8a\u7a7a\u767d\uff0c\u5e76\u5728\u83b7\u6279\u540e\u7684\u9996\u4e2a\u533b\u4fdd\u5e74\u5ea6\u5373\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u76ee\u5f55\uff0c\u6210\u4e3a\u76ee\u524d\u552f\u4e00\u83b7\u6279\u4e14\u53ef\u533b\u4fdd\u62a5\u9500\u7684EGFR exon20ins NSCLC\u4e8c\/\u540e\u7ebf\u6807\u51c6\u6cbb\u7597\u65b9\u6848\uff0c\u83b7\u4e2d\u56fd\u5404\u5927\u6743\u5a01\u6307\u5357\u6700\u9ad8\u7b49\u7ea7\u63a8\u8350\u3002\u57fa\u4e8e\u4f18\u5f02\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\uff0c\u8212\u6c83\u54f2\u00ae\u662f\u5f53\u524dEGFR exon20ins NSCLC\u6cbb\u7597\u9886\u57df\u5168\u7403\u552f\u4e00\u5168\u7ebf\u62e5\u6709\u4e2d\u3001\u7f8e”\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a”\uff08Breakthrough Therapy Designation\uff0cBTD\uff09”\u5927\u6ee1\u8d2f”\u7684\u836f\u7269\uff0c\u5e76\u5728\u7f8e\u56fd\u9012\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Application\uff0cNDA\uff09\u540e\u88abFDA\u6388\u4e88\u4f18\u5148\u5ba1\u8bc4\uff08Priority Review\uff09\u8d44\u683c\u3002<\/p>\n

\u6b64\u6b21\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u83b7FDA\u6279\u51c6\uff0c\u662f\u57fa\u4e8e\u8212\u6c83\u54f2\u00ae\u5728\u56fd\u9645\u591a\u4e2d\u5fc3\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76”\u609f\u7a7a1B”\uff08WU-KONG1B\uff09\u4e2d\uff0c\u9488\u5bf9\u7ecf\u6cbbEGFR exon20ins NSCLC\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u6570\u636e\u3002\u8be5\u9879\u7814\u7a76\u6210\u679c\u57282024\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u4f1a\u4ee5\u53e3\u5934\u62a5\u544a\u5f62\u5f0f\u516c\u5e03\uff0c\u5e76\u4e8e\u8fd1\u65e5\u5168\u6587\u53d1\u8868\u4e8e\u56fd\u9645\u9876\u7ea7\u6742\u5fd7\u300a\u4e34\u5e8a\u80bf\u7624\u5b66\u671f\u520a\u300b\uff08Journal of Clinical Oncology\uff0c\u5f71\u54cd\u56e0\u5b50\uff1a42.1\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u8fdb\u4e00\u6b65\u5728\u5168\u7403\u8303\u56f4\u5185\u8bc1\u660e\u4e86\u8212\u6c83\u54f2\u00ae”\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\u3001\u6f5c\u5728\u540c\u7c7b\u6700\u4f73”\u3002<\/p>\n

“\u609f\u7a7a1B<\/span>“\uff08WU-KONG1B\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001\u7f8e\u56fd\u54c8\u4f5b\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u4e39\u5a1c\u6cd5\u4f2f\u764c\u75c7\u7814\u7a76\u9662\uff08Dana-Farber Cancer Institute\uff09Pasi A. J\u00e4nne\u6559\u6388\u8868\u793a\uff1a”\u4f5c\u4e3a\u5168\u7403\u552f\u4e00\u83b7\u6279\u7684EGFR exon20ins NSCLC\u9776\u5411\u53e3\u670d\u7597\u6cd5\uff0c\u8212\u6c83\u66ff\u5c3c\u7684\u4e34\u5e8a\u6570\u636e\u91cd\u5851\u4e86\u8fd9\u4e00\u9886\u57df\u957f\u671f\u7f3a\u4e4f\u65b9\u4fbf\u6709\u6548\u6cbb\u7597\u624b\u6bb5\u7684\u5386\u53f2\u3002WU-KONG1B\u7684\u6570\u636e\u8bc1\u5b9e\uff0c\u8212\u6c83\u66ff\u5c3c\u5c55\u73b0\u51fa\u663e\u8457\u7684\u7597\u6548\u4f18\u52bf\uff0c\u4e14\u5728\u975e\u4e9a\u88d4\u60a3\u8005\u7fa4\u4f53\u4e2d\u5f97\u5230\u540c\u6837\u9a8c\u8bc1\u3002\u6b64\u5916\uff0c\u5176\u6bcf\u65e5\u4e00\u6b21\u7684\u53e3\u670d\u7ed9\u836f\u65b9\u5f0f\u6781\u5927\u7684\u63d0\u5347\u4e86\u6cbb\u7597\u4fbf\u5229\u6027\u548c\u60a3\u8005\u4f9d\u4ece\u6027\uff0c\u8fd9\u5728\u80ba\u764c\u6162\u75c5\u5316\u7ba1\u7406\u8d8b\u52bf\u4e2d\u5177\u6709\u81f3\u5173\u91cd\u8981\u7684\u4e34\u5e8a\u4ef7\u503c\u3002\u8212\u6c83\u66ff\u5c3c\u5728\u7f8e\u83b7\u6279\u4ee3\u8868\u7740\u79d1\u5b66\u521b\u65b0\u7684\u91cd\u8981\u7a81\u7834\uff0c\u66f4\u662f\u5bf9\u5168\u7403\u60a3\u8005\u957f\u671f\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u7684\u91cc\u7a0b\u7891\u5f0f\u56de\u5e94\u3002”<\/p>\n

“\u609f\u7a7a1B<\/span>“\uff08WU-KONG1B\uff09\u53e6\u4e00\u4f4d\u4e3b\u8981\u7814\u7a76\u8005\u3001\u53f0\u6e7e\u5927\u5b66\u764c\u533b\u4e2d\u5fc3\u5206\u9662\u6768\u5fd7\u65b0\u6559\u6388\u8868\u793a\uff1a\u201c\u4f5c\u4e3a\u6b64\u9879\u7814\u7a76\u7684\u6df1\u5ea6\u53c2\u4e0e\u8005\uff0c\u6211\u4eec\u901a\u8fc7\u4e25\u8c28\u7684\u8de8\u56fd\u4e34\u5e8a\u8bd5\u9a8c\u8bc1\u5b9e\u4e86\u8212\u6c83\u66ff\u5c3c\u5728EGFR exon20ins NSCLC\u6cbb\u7597\u7684\u7a81\u7834\u6027\u4ef7\u503c\uff0c\u8fd9\u79cd\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\u4e14\u53e3\u670d\u4fbf\u5229\u7684\u7279\u6027\uff0c\u4f7f\u5176\u6210\u4e3a\u4e34\u5e8a\u5b9e\u8df5\u4e2d\u7684\u7406\u60f3\u9009\u62e9\uff0c\u6253\u7834\u4e86\u957f\u671f\u4ee5\u6765<\/span>EGFR exon20ins\u7f3a\u4e4f\u517c\u5177\u2018\u7597\u6548\u3001\u5b89\u5168\u6027\u3001\u4fbf\u5229\u6027\u2019\u5c0f\u5206\u5b50\u53e3\u670d\u9776\u5411\u836f\u7269\u6cbb\u7597\u7684\u50f5\u5c40\u3002<\/span>\u8212\u6c83\u66ff\u5c3c\u5728\u5168\u7403\u4e3b\u8981\u5e02\u573a\u7684\u4e0a\u5e02\uff0c\u4e0d\u4ec5\u70b9\u71c3\u4e86\u60a3\u8005\u7684\u5e0c\u671b\uff0c\u66f4\u575a\u5b9a\u4e86\u6211\u4eec\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\uff0c\u6301\u7eed\u63a8\u8fdb\u80ba\u764c\u7cbe\u51c6\u6cbb\u7597\u4e0d\u65ad\u5411\u524d\u7684\u4fe1\u5ff5\u3002\u201d \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/p>\n

\u8212\u6c83\u54f2\u00ae\u4e2d\u56fd\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\uff08\u609f\u7a7a6\uff0cWU-KONG6\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001”\u609f\u7a7a1B<\/span>“\uff08WU-KONG1B\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001\u5317\u4eac\u534f\u548c\u533b\u9662\u738b\u5b5f\u662d\u6559\u6388\u8868\u793a\uff1a”EGFR exon20ins \u662fEGFR\u7684\u7b2c\u4e09\u5927\u539f\u53d1\u7a81\u53d8\uff0c\u56e0\u5176\u72ec\u7279\u7684\u7a7a\u95f4\u6784\u8c61\uff0c\u4f20\u7edf\u7684EGFR TKI\u96be\u4ee5\u4e0e\u8be5\u9776\u70b9\u7ed3\u5408\uff0c\u60a3\u8005\u6cbb\u7597\u9009\u62e9\u6709\u9650\uff0c\u9884\u540e\u8f83\u5dee\uff0c\u4e00\u76f4\u4ee5\u6765\u662f\u5168\u7403\u80ba\u764c\u65b0\u836f\u7814\u53d1\u4e2d\u6781\u5177\u6311\u6218\u6027\u7684\u96be\u9898\u3002\u2018\u609f\u7a7a6’\uff08WU-KONG6\uff09\u7814\u7a76\u6210\u679c\u9a8c\u8bc1\u4e86\u8212\u6c83\u66ff\u5c3c\u7a81\u7834EGFR exon20ins NSCLC\u6cbb\u7597\u74f6\u9888\uff0c\u63a8\u52a8\u4e86\u5176\u5728\u56fd\u5185\u83b7\u6279\u4e0a\u5e02\uff0c\u4f7f\u5f97\u4e2d\u56fd\u60a3\u8005\u80fd\u7387\u5148\u53d7\u76ca\u4e8e\u5177\u6709\u56fd\u9645\u9886\u5148\u6c34\u5e73\u7684\u521b\u65b0\u7597\u6cd5\u3002\u5982\u4eca\uff0c\u8212\u6c83\u66ff\u5c3c\u5728\u7f8e\u56fd\u6210\u529f\u83b7\u6279\uff0c\u4f5c\u4e3a\u7814\u7a76\u8005\uff0c\u4e3a\u6765\u81ea\u4e2d\u56fd\u7684\u6e90\u5934\u521b\u65b0\u6210\u679c\u8d70\u5411\u4e16\u754c\uff0c\u8fdb\u4e00\u6b65\u60e0\u53ca\u5168\u7403\u60a3\u8005\u800c\u6df1\u611f\u81ea\u8c6a\u3002”<\/p>\n

FDA\u540c\u65f6\u6279\u51c6\u4e86\u8d5b\u9ed8\u98de\u4e16\u5c14\u79d1\u6280\u516c\u53f8\uff08Thermo Fisher Scientific\uff09\u7684OncomineTM Dx Express Test\u4f5c\u4e3a\u8212\u6c83\u54f2\u00ae\u5728\u7f8e\u56fd\u7684\u57fa\u4e8e\u4e8c\u4ee3\u6d4b\u5e8f\uff08NGS\uff09\u7684\u4f34\u968f\u8bca\u65ad\u8bd5\u5242\uff08CDx\uff09\uff0c\u7528\u4e8e\u68c0\u6d4bNSCLC\u60a3\u8005\u662f\u5426\u643a\u5e26EGFR exon20ins\u3002\u5bf9\u4e8eEGFR exon20ins NSCLC\u60a3\u8005\u800c\u8a00\uff0cNGS\u68c0\u6d4b\u9ad8\u6548\u3001\u7cbe\u51c6\uff0c\u5176\u4e0eIon TorrentTM GenexusTM Dx\u7cfb\u7edf\u7ed3\u5408\u4f7f\u7528\uff0c\u6700\u5feb\u53ef\u572824\u5c0f\u65f6\u5185\u63d0\u4f9b\u68c0\u6d4b\u7ed3\u679c\uff0c\u80fd\u591f\u53ca\u65f6\u5730\u4e3a\u4e34\u5e8a\u7528\u836f\u51b3\u7b56\u63d0\u4f9b\u5173\u952e\u4f9d\u636e\u3002\u76ee\u524d\uff0cNGS\u68c0\u6d4b\u6280\u672f\u5df2\u6210\u4e3a\u80bf\u7624\u57fa\u56e0\u68c0\u6d4b\u9886\u57df\u7684\u5173\u952e\u6280\u672f\u4e4b\u4e00\u3002<\/p>\n

\u6b64\u5916\uff0c\u8212\u6c83\u54f2\u00ae\u4e00\u7ebf\u6cbb\u7597EGFR exon20ins NSCLC\u7684\u5168\u7403\u2162\u671f\u786e\u8bc1\u6027\u4e34\u5e8a\u7814\u7a76”\u609f\u7a7a28″\uff08WU-KONG28\uff09\u5df2\u4e8e\u8fd1\u65e5\u5b8c\u6210\u5168\u90e8\u60a3\u8005\u5165\u7ec4\uff0c\u6b63\u5728\u5168\u740316\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u79ef\u6781\u5f00\u5c55\u3002\u4e00\u9879\u4e8e2023\u5e74\u6b27\u6d32\u5185\u79d1\u80bf\u7624\u5b66\u4f1a\uff08ESMO\uff09\u5e74\u4f1a\u516c\u5e03\u7684\u6c47\u603b\u5206\u6790\u663e\u793a\uff0c\u8212\u6c83\u54f2\u00ae\u5355\u836f\u4e00\u7ebf\u6cbb\u7597EGFR exon20ins NSCLC\u7ecf\u786e\u8ba4\u7684\u5ba2\u89c2\u7f13\u89e3\u7387\uff08ORR\uff09\u8fbe78.6%\uff0c\u4e2d\u4f4d\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08mPFS\uff09\u4e3a12.4\u4e2a\u6708\uff0c\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\uff0c\u6709\u671b\u8fdb\u4e00\u6b65\u91cd\u5851\u8be5\u9886\u57df\u4e00\u7ebf\u6cbb\u7597\u683c\u5c40\u3002<\/span><\/p>\n

\u5173\u4e8e\u8212\u6c83\u54f2\u00ae\uff08\u8212\u6c83\u66ff\u5c3c\u7247\uff09<\/p>\n

\u8212\u6c83\u54f2\u00ae\u662f\u4e00\u6b3e\u53e3\u670d\u3001\u4e0d\u53ef\u9006\u3001\u9488\u5bf9\u591a\u79cdEGFR\u7a81\u53d8\u4e9a\u578b\u7684\u9ad8\u9009\u62e9\u6027EGFR\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\uff0c\u9996\u4e2a\u9002\u5e94\u75c7\u4e8e2023\u5e748\u6708\u83b7\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u5728\u4e2d\u56fd\u6279\u51c6\u4e0a\u5e02\uff0c\u7528\u4e8e\u65e2\u5f80\u7ecf\u542b\u94c2\u5316\u7597\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u6216\u4e0d\u8010\u53d7\u542b\u94c2\u5316\u7597\uff0c\u5e76\u4e14\u7ecf\u68c0\u6d4b\u786e\u8ba4\u5b58\u5728\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u7684\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u30022024\u5e744\u6708\uff0c\u8212\u6c83\u54f2\u00ae\u4f5c\u4e3aEGFR exon20ins NSCLC\u4e8c\/\u540e\u7ebf\u6cbb\u7597\u7684\u552f\u4e00\u2160\u7ea7\u63a8\u8350\u65b9\u6848\uff0c\u88ab\u5217\u5165\u300a\u4e2d\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08CSCO\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u8bca\u7597\u6307\u5357\uff082024\u7248\uff09\u300b\uff0c\u968f\u540e\uff0c\u9646\u7eed\u88ab\u5217\u5165\u5176\u4ed6\u4e2d\u56fd\u5404\u5927\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u6743\u5a01\u6307\u5357\u5e76\u83b7\u5f97\u6700\u9ad8\u7b49\u7ea7\u63a8\u8350\u3002\u8212\u6c83\u54f2\u00ae\u83b7\u6279\u9002\u5e94\u75c7\u5df2\u7eb3\u5165\u300a\u56fd\u5bb6\u57fa\u672c\u533b\u7597\u4fdd\u9669\u3001\u5de5\u4f24\u4fdd\u9669\u548c\u751f\u80b2\u4fdd\u9669\u836f\u54c1\u76ee\u5f55\uff082024\u5e74\uff09\u300b\u30022025\u5e747<\/span>\u6708\uff0c\u8212\u6c83\u54f2\u00ae\u4e8c\/\u540e\u7ebf\u6cbb\u7597EGFR exon20ins NSCLC\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\u83b7\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\u5728\u7f8e\u56fd\u4e0a\u5e02\u3002<\/p>\n

\u5173\u4e8e\u8fea\u54f2\u533b\u836f<\/p>\n

\u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u662f\u4e00\u5bb6\u521b\u65b0\u578b\u751f\u7269\u533b\u836f\u4f01\u4e1a\uff0c\u4e13\u6ce8\u4e8e\u6076\u6027\u80bf\u7624\u3001\u514d\u75ab\u6027\u75be\u75c5\u9886\u57df\u521b\u65b0\u7597\u6cd5\u7684\u7814\u7a76\u3001\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u3002\u516c\u53f8\u575a\u6301\u6e90\u5934\u521b\u65b0\u7684\u7814\u53d1\u7406\u5ff5\uff0c\u4ee5\u63a8\u51fa\u5168\u7403\u9996\u521b\u836f\u7269\uff08First-in-class\uff09\u548c\u5177\u6709\u7a81\u7834\u6027\u6f5c\u529b\u7684\u6cbb\u7597\u65b9\u6cd5\u4e3a\u76ee\u6807\uff0c\u65e8\u5728\u586b\u8865\u5168\u7403\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u3002\u57fa\u4e8e\u884c\u4e1a\u9886\u5148\u7684\u8f6c\u5316\u79d1\u5b66\u548c\u65b0\u836f\u5206\u5b50\u8bbe\u8ba1\u4e0e\u7b5b\u9009\u6280\u672f\u5e73\u53f0\uff0c\u516c\u53f8\u5df2\u5efa\u7acb\u4e86\u4e03\u6b3e\u5177\u5907\u5168\u7403\u7ade\u4e89\u529b\u7684\u4ea7\u54c1\u7ba1\u7ebf\uff0c\u5176\u4e2d\u5168\u7403\u5173\u952e\u6027\u4e34\u5e8a\u8bd5\u9a8c\u5df2\u8fbe\u5230\u4e3b\u8981\u7814\u7a76\u7ec8\u70b9\u7684\u4e24\u5927\u9886\u5148\u4ea7\u54c1\u2014\u2014\u8212\u6c83\u54f2\u00ae\u5df2\u5728\u4e2d\u3001\u7f8e\u4e24\u56fd\u83b7\u6279\u4e0a\u5e02\uff0c\u9ad8\u745e\u54f2\u00ae\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u5173\u6ce8\u5fae\u4fe1\u516c\u4f17\u53f7\uff1a\u8fea\u54f2Dizal\uff0c\u6216\u8bbf\u95eewww.dizalpharma.com<\/a>\u3002<\/p>\n

\u524d\u77bb\u6027\u58f0\u660e<\/p>\n

\u672c\u65b0\u95fb\u6240\u53d1\u5e03\u7684\u4fe1\u606f\u4e2d\u53ef\u80fd\u4f1a\u5305\u542b\u67d0\u4e9b\u524d\u77bb\u6027\u8868\u8ff0\u3002\u8fd9\u4e9b\u8868\u8ff0\u672c\u8d28\u4e0a\u5177\u6709\u76f8\u5f53\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\u3002\u5728\u4f7f\u7528”\u9884\u671f”\u3001”\u76f8\u4fe1”\u3001”\u9884\u6d4b”\u3001”\u671f\u671b”\u3001”\u6253\u7b97”\u3001”\u6709\u671b”\u53ca\u5176\u4ed6\u7c7b\u4f3c\u8bcd\u8bed\u8fdb\u884c\u8868\u8ff0\u65f6\uff0c\u51e1\u4e0e\u672c\u516c\u53f8\u6709\u5173\u7684\uff0c\u76ee\u7684\u5747\u662f\u8981\u6307\u660e\u5176\u5c5e\u524d\u77bb\u6027\u8868\u8ff0\u3002<\/p>\n

\u524d\u77bb\u6027\u8868\u8ff0\u4e43\u57fa\u4e8e\u672c\u516c\u53f8\u7ba1\u7406\u5c42\u5728\u505a\u51fa\u8868\u8ff0\u65f6\u5bf9\u672a\u6765\u4e8b\u52a1\u7684\u73b0\u6709\u770b\u6cd5\u3001\u5047\u8bbe\u3001\u671f\u671b\u3001\u4f30\u8ba1\u3001\u9884\u6d4b\u548c\u7406\u89e3\u3002\u8fd9\u4e9b\u8868\u8ff0\u5e76\u975e\u5bf9\u672a\u6765\u53d1\u5c55\u7684\u4fdd\u8bc1\uff0c\u4f1a\u53d7\u5230\u98ce\u9669\u3001\u4e0d\u786e\u6027\u53ca\u5176\u4ed6\u56e0\u7d20\u7684\u5f71\u54cd\uff0c\u6709\u4e9b\u4e43\u8d85\u51fa\u672c\u516c\u53f8\u7684\u63a7\u5236\u8303\u56f4\uff0c\u96be\u4ee5\u9884\u8ba1\u3002\u56e0\u6b64\uff0c\u53d7\u6211\u4eec\u7684\u4e1a\u52a1\u3001\u7ade\u4e89\u73af\u5883\u3001\u653f\u6cbb\u3001\u7ecf\u6d4e\u3001\u6cd5\u5f8b\u548c\u793e\u4f1a\u60c5\u51b5\u7684\u672a\u6765\u53d8\u5316\u53ca\u53d1\u5c55\u7684\u5f71\u54cd\uff0c\u5b9e\u9645\u7ed3\u679c\u53ef\u80fd\u4f1a\u4e0e\u524d\u77bb\u6027\u8868\u8ff0\u6240\u542b\u8d44\u6599\u6709\u8f83\u5927\u5dee\u522b\u3002<\/p>\n

\u672c\u516c\u53f8\u3001\u672c\u516c\u53f8\u8463\u4e8b\u53ca\u96c7\u5458\u6982\u4e0d\u627f\u62c5\uff08a\uff09\u66f4\u6b63\u6216\u66f4\u65b0\u672c\u7f51\u7ad9\u6240\u8f7d\u524d\u77bb\u6027\u8868\u8ff0\u7684\u4efb\u4f55\u4e49\u52a1\uff1b\u53ca\uff08b\uff09 \u82e5\u56e0\u4efb\u4f55\u524d\u77bb\u6027\u8868\u8ff0\u4e0d\u80fd\u5b9e\u73b0\u6216\u53d8\u6210\u4e0d\u6b63\u786e\u800c\u5f15\u81f4\u7684\u4efb\u4f55\u8d23\u4efb\u3002<\/p>\n

\u66f4\u591a\u4fe1\u606f\uff0c\u656c\u8bf7\u8054\u7cfb<\/p>\n

\u6295\u8d44\u8005\u5173\u7cfb\uff1air@dizalpharma.com<\/a><\/p>\n

\u5546\u52a1\u5408\u4f5c\uff1abd@dizalpharma.com<\/a><\/p>\n

\u5a92\u4f53\u8054\u7edc\uff1apr@dizalpharma.com<\/a><\/p>\n

\u00a0<\/p>\n

SOURCE \u8fea\u54f2\u533b\u836f<\/p>","protected":false},"excerpt":{"rendered":"

\u8212\u6c83\u54f2\u00ae\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\uff0c\u6210\u4e3a\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u5728\u7f8e\u56fd\u83b7\u6279\u7684\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u56fd\u521b\u65b0\u836f\uff0c\u540c\u65f6\u4e5f\u662f\u4e2d\u56fd\u9996\u4e2a\u72ec\u7acb\u7814\u53d1\u5728\u7f8e\u83b7\u6279\u7684\u5168\u7403\u9996\u521b\u65b0\u836f\u6b64\u6b21\u52a0\u901f\u6279\u51c6\u57fa\u4e8e\u56fd\u9645\u591a\u4e2d\u5fc3\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\uff08\u609f\u7a7a1B,WU-KONG1B\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u5c55\u73b0\u8212\u6c83\u54f2\u00ae\u9488\u5bf9\u7ecf\u6cbbEGFR exon20ins NSCLC\u5168\u7403\u540c\u7c7b\u6700\u4f73\uff08Best-in-Class\uff09\u6f5c\u529b \u4e0a\u6d772025\u5e747\u67083\u65e5 \/\u7f8e\u901a\u793e\/ — \u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u5ba3\u5e03\uff0c\u8212\u6c83\u54f2\u00ae\uff08ZEGFROVY\u00ae\uff0c\u901a\u7528\u540d\uff1a\u8212\u6c83\u66ff\u5c3c\u7247\uff09\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Application\uff0cNDA\uff09\uff0c\u6b63\u5f0f\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\uff0c\u7528\u4e8e\u65e2\u5f80\u7ecf\u542b\u94c2\u5316\u7597\u6cbb\u7597\u65f6\u6216\u6cbb\u7597\u540e\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u5e76\u4e14\u7ecfFDA\u6279\u51c6\u7684\u8bd5\u5242\u76d2\u68c0\u6d4b\u786e\u8ba4\uff0c\u5b58\u5728\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u7684\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u7684\u6210\u4eba\u60a3\u8005\u3002 \u8212\u6c83\u54f2\u00ae\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\u83b7\u5f97\u6279\u51c6\u4e0a\u5e02\uff0c\u6210\u4e3a\u76ee\u524d\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins NSCLC\u56fd\u521b\u65b0\u836f\u3002\u5176\u5728\u5206\u5b50\u8bbe\u8ba1\u7684\u6e90\u5934\u8fdb\u884c\u4e86\u91cd\u5927\u521b\u65b0\uff0c\u7a81\u7834\u96be\u6cbb\u9776\u70b9\uff0c\u662f\u4e2d\u56fd\u9996\u4e2a\u72ec\u7acb\u7814\u53d1\u5728\u7f8e\u83b7\u6279\u7684\u5168\u7403\u9996\u521b\u65b0\u836f\u3002 \u8fea\u54f2\u533b\u836f\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5f20\u5c0f\u6797\u535a\u58eb\u8868\u793a\uff1a”\u4f5c\u4e3a\u516c\u53f8\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684\u521b\u65b0\u836f\uff0c\u8212\u6c83\u54f2\u00ae\u7684\u52a0\u901f\u83b7\u6279\u4e0d\u4ec5\u4e3a\u5168\u7403EGFR 20\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u5e26\u6765\u5168\u65b0\u6cbb\u7597\u65b9\u6848\uff0c\u66f4\u4ee5\u4e2d\u56fd\u6e90\u5934\u521b\u65b0\u8fc8\u51fa\u2018\u79d1\u6280\u521b\u65b0\u5f15\u9886\u5168\u7403’\u5f81\u7a0b\u4e0a\u7684\u65b0\u8de8\u8d8a\u3002\u8212\u6c83\u54f2\u00ae\u662f\u76ee\u524d\u5168\u7403\u552f\u4e00\u83b7\u6279\u6cbb\u7597EGFR exon20ins NSCLC\u7684\u53e3\u670d\u5c0f\u5206\u5b50\u9776\u5411\u836f\uff0c\u5177\u5907\u7597\u6548\u3001\u5b89\u5168\u6027\u53ca\u4fbf\u5229\u6027\u5168\u7403\u540c\u7c7b\u6700\u4f73\u7684\u6f5c\u5728\u4f18\u52bf\u3002\u8fd9\u4e00\u5728\u7f8e\u83b7\u6279\u7684\u91cc\u7a0b\u7891\u4e8b\u4ef6\uff0c\u8fdb\u4e00\u6b65\u575a\u5b9a\u4e86\u8fea\u54f2\u533b\u836f\u81f4\u529b\u4e8e\u4ee5\u7a81\u7834\u6027\u521b\u65b0\u7597\u6cd5\u586b\u8865\u5168\u7403\u672a\u88ab\u6ee1\u8db3\u4e34\u5e8a\u9700\u6c42\u7684\u6218\u7565\u51b3\u5fc3\u3002” \u8212\u6c83\u54f2\u00ae\u662f\u4e00\u6b3e\u53e3\u670d\u3001\u4e0d\u53ef\u9006\u4e14\u9488\u5bf9\u591a\u79cdEGFR\u7a81\u53d8\u4e9a\u578b\u7684\u9ad8\u9009\u62e9\u6027EGFR\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\uff0c\u4e8e2023\u5e748\u6708\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\uff0c\u586b\u8865\u4e86\u8be5\u9886\u57df\u8fd120\u5e74\u4e34\u5e8a\u7a7a\u767d\uff0c\u5e76\u5728\u83b7\u6279\u540e\u7684\u9996\u4e2a\u533b\u4fdd\u5e74\u5ea6\u5373\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u76ee\u5f55\uff0c\u6210\u4e3a\u76ee\u524d\u552f\u4e00\u83b7\u6279\u4e14\u53ef\u533b\u4fdd\u62a5\u9500\u7684EGFR exon20ins NSCLC\u4e8c\/\u540e\u7ebf\u6807\u51c6\u6cbb\u7597\u65b9\u6848\uff0c\u83b7\u4e2d\u56fd\u5404\u5927\u6743\u5a01\u6307\u5357\u6700\u9ad8\u7b49\u7ea7\u63a8\u8350\u3002\u57fa\u4e8e\u4f18\u5f02\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\uff0c\u8212\u6c83\u54f2\u00ae\u662f\u5f53\u524dEGFR exon20ins NSCLC\u6cbb\u7597\u9886\u57df\u5168\u7403\u552f\u4e00\u5168\u7ebf\u62e5\u6709\u4e2d\u3001\u7f8e”\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a”\uff08Breakthrough Therapy Designation\uff0cBTD\uff09”\u5927\u6ee1\u8d2f”\u7684\u836f\u7269\uff0c\u5e76\u5728\u7f8e\u56fd\u9012\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Application\uff0cNDA\uff09\u540e\u88abFDA\u6388\u4e88\u4f18\u5148\u5ba1\u8bc4\uff08Priority Review\uff09\u8d44\u683c\u3002 \u6b64\u6b21\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u83b7FDA\u6279\u51c6\uff0c\u662f\u57fa\u4e8e\u8212\u6c83\u54f2\u00ae\u5728\u56fd\u9645\u591a\u4e2d\u5fc3\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76”\u609f\u7a7a1B”\uff08WU-KONG1B\uff09\u4e2d\uff0c\u9488\u5bf9\u7ecf\u6cbbEGFR exon20ins NSCLC\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u6570\u636e\u3002\u8be5\u9879\u7814\u7a76\u6210\u679c\u57282024\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u4f1a\u4ee5\u53e3\u5934\u62a5\u544a\u5f62\u5f0f\u516c\u5e03\uff0c\u5e76\u4e8e\u8fd1\u65e5\u5168\u6587\u53d1\u8868\u4e8e\u56fd\u9645\u9876\u7ea7\u6742\u5fd7\u300a\u4e34\u5e8a\u80bf\u7624\u5b66\u671f\u520a\u300b\uff08Journal of Clinical Oncology\uff0c\u5f71\u54cd\u56e0\u5b50\uff1a42.1\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u8fdb\u4e00\u6b65\u5728\u5168\u7403\u8303\u56f4\u5185\u8bc1\u660e\u4e86\u8212\u6c83\u54f2\u00ae”\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\u3001\u6f5c\u5728\u540c\u7c7b\u6700\u4f73”\u3002 “\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001\u7f8e\u56fd\u54c8\u4f5b\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u4e39\u5a1c\u6cd5\u4f2f\u764c\u75c7\u7814\u7a76\u9662\uff08Dana-Farber Cancer Institute\uff09Pasi A. J\u00e4nne\u6559\u6388\u8868\u793a\uff1a”\u4f5c\u4e3a\u5168\u7403\u552f\u4e00\u83b7\u6279\u7684EGFR exon20ins NSCLC\u9776\u5411\u53e3\u670d\u7597\u6cd5\uff0c\u8212\u6c83\u66ff\u5c3c\u7684\u4e34\u5e8a\u6570\u636e\u91cd\u5851\u4e86\u8fd9\u4e00\u9886\u57df\u957f\u671f\u7f3a\u4e4f\u65b9\u4fbf\u6709\u6548\u6cbb\u7597\u624b\u6bb5\u7684\u5386\u53f2\u3002WU-KONG1B\u7684\u6570\u636e\u8bc1\u5b9e\uff0c\u8212\u6c83\u66ff\u5c3c\u5c55\u73b0\u51fa\u663e\u8457\u7684\u7597\u6548\u4f18\u52bf\uff0c\u4e14\u5728\u975e\u4e9a\u88d4\u60a3\u8005\u7fa4\u4f53\u4e2d\u5f97\u5230\u540c\u6837\u9a8c\u8bc1\u3002\u6b64\u5916\uff0c\u5176\u6bcf\u65e5\u4e00\u6b21\u7684\u53e3\u670d\u7ed9\u836f\u65b9\u5f0f\u6781\u5927\u7684\u63d0\u5347\u4e86\u6cbb\u7597\u4fbf\u5229\u6027\u548c\u60a3\u8005\u4f9d\u4ece\u6027\uff0c\u8fd9\u5728\u80ba\u764c\u6162\u75c5\u5316\u7ba1\u7406\u8d8b\u52bf\u4e2d\u5177\u6709\u81f3\u5173\u91cd\u8981\u7684\u4e34\u5e8a\u4ef7\u503c\u3002\u8212\u6c83\u66ff\u5c3c\u5728\u7f8e\u83b7\u6279\u4ee3\u8868\u7740\u79d1\u5b66\u521b\u65b0\u7684\u91cd\u8981\u7a81\u7834\uff0c\u66f4\u662f\u5bf9\u5168\u7403\u60a3\u8005\u957f\u671f\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u7684\u91cc\u7a0b\u7891\u5f0f\u56de\u5e94\u3002” “\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u53e6\u4e00\u4f4d\u4e3b\u8981\u7814\u7a76\u8005\u3001\u53f0\u6e7e\u5927\u5b66\u764c\u533b\u4e2d\u5fc3\u5206\u9662\u6768\u5fd7\u65b0\u6559\u6388\u8868\u793a\uff1a\u201c\u4f5c\u4e3a\u6b64\u9879\u7814\u7a76\u7684\u6df1\u5ea6\u53c2\u4e0e\u8005\uff0c\u6211\u4eec\u901a\u8fc7\u4e25\u8c28\u7684\u8de8\u56fd\u4e34\u5e8a\u8bd5\u9a8c\u8bc1\u5b9e\u4e86\u8212\u6c83\u66ff\u5c3c\u5728EGFR exon20ins NSCLC\u6cbb\u7597\u7684\u7a81\u7834\u6027\u4ef7\u503c\uff0c\u8fd9\u79cd\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\u4e14\u53e3\u670d\u4fbf\u5229\u7684\u7279\u6027\uff0c\u4f7f\u5176\u6210\u4e3a\u4e34\u5e8a\u5b9e\u8df5\u4e2d\u7684\u7406\u60f3\u9009\u62e9\uff0c\u6253\u7834\u4e86\u957f\u671f\u4ee5\u6765EGFR exon20ins\u7f3a\u4e4f\u517c\u5177\u2018\u7597\u6548\u3001\u5b89\u5168\u6027\u3001\u4fbf\u5229\u6027\u2019\u5c0f\u5206\u5b50\u53e3\u670d\u9776\u5411\u836f\u7269\u6cbb\u7597\u7684\u50f5\u5c40\u3002\u8212\u6c83\u66ff\u5c3c\u5728\u5168\u7403\u4e3b\u8981\u5e02\u573a\u7684\u4e0a\u5e02\uff0c\u4e0d\u4ec5\u70b9\u71c3\u4e86\u60a3\u8005\u7684\u5e0c\u671b\uff0c\u66f4\u575a\u5b9a\u4e86\u6211\u4eec\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\uff0c\u6301\u7eed\u63a8\u8fdb\u80ba\u764c\u7cbe\u51c6\u6cbb\u7597\u4e0d\u65ad\u5411\u524d\u7684\u4fe1\u5ff5\u3002\u201d \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u8212\u6c83\u54f2\u00ae\u4e2d\u56fd\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\uff08\u609f\u7a7a6\uff0cWU-KONG6\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001”\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001\u5317\u4eac\u534f\u548c\u533b\u9662\u738b\u5b5f\u662d\u6559\u6388\u8868\u793a\uff1a”EGFR exon20ins \u662fEGFR\u7684\u7b2c\u4e09\u5927\u539f\u53d1\u7a81\u53d8\uff0c\u56e0\u5176\u72ec\u7279\u7684\u7a7a\u95f4\u6784\u8c61\uff0c\u4f20\u7edf\u7684EGFR TKI\u96be\u4ee5\u4e0e\u8be5\u9776\u70b9\u7ed3\u5408\uff0c\u60a3\u8005\u6cbb\u7597\u9009\u62e9\u6709\u9650\uff0c\u9884\u540e\u8f83\u5dee\uff0c\u4e00\u76f4\u4ee5\u6765\u662f\u5168\u7403\u80ba\u764c\u65b0\u836f\u7814\u53d1\u4e2d\u6781\u5177\u6311\u6218\u6027\u7684\u96be\u9898\u3002\u2018\u609f\u7a7a6’\uff08WU-KONG6\uff09\u7814\u7a76\u6210\u679c\u9a8c\u8bc1\u4e86\u8212\u6c83\u66ff\u5c3c\u7a81\u7834EGFR exon20ins NSCLC\u6cbb\u7597\u74f6\u9888\uff0c\u63a8\u52a8\u4e86\u5176\u5728\u56fd\u5185\u83b7\u6279\u4e0a\u5e02\uff0c\u4f7f\u5f97\u4e2d\u56fd\u60a3\u8005\u80fd\u7387\u5148\u53d7\u76ca\u4e8e\u5177\u6709\u56fd\u9645\u9886\u5148\u6c34\u5e73\u7684\u521b\u65b0\u7597\u6cd5\u3002\u5982\u4eca\uff0c\u8212\u6c83\u66ff\u5c3c\u5728\u7f8e\u56fd\u6210\u529f\u83b7\u6279\uff0c\u4f5c\u4e3a\u7814\u7a76\u8005\uff0c\u4e3a\u6765\u81ea\u4e2d\u56fd\u7684\u6e90\u5934\u521b\u65b0\u6210\u679c\u8d70\u5411\u4e16\u754c\uff0c\u8fdb\u4e00\u6b65\u60e0\u53ca\u5168\u7403\u60a3\u8005\u800c\u6df1\u611f\u81ea\u8c6a\u3002” […]<\/p>\n","protected":false},"author":0,"featured_media":13252,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-13251","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"\n\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f - Money Compass CN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/moneycompass.com.my\/cn\/\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u83b7fda\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f - Money Compass CN\" \/>\n<meta property=\"og:description\" content=\"\u8212\u6c83\u54f2\u00ae\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\uff0c\u6210\u4e3a\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u5728\u7f8e\u56fd\u83b7\u6279\u7684\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u56fd\u521b\u65b0\u836f\uff0c\u540c\u65f6\u4e5f\u662f\u4e2d\u56fd\u9996\u4e2a\u72ec\u7acb\u7814\u53d1\u5728\u7f8e\u83b7\u6279\u7684\u5168\u7403\u9996\u521b\u65b0\u836f\u6b64\u6b21\u52a0\u901f\u6279\u51c6\u57fa\u4e8e\u56fd\u9645\u591a\u4e2d\u5fc3\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\uff08\u609f\u7a7a1B,WU-KONG1B\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u5c55\u73b0\u8212\u6c83\u54f2\u00ae\u9488\u5bf9\u7ecf\u6cbbEGFR exon20ins NSCLC\u5168\u7403\u540c\u7c7b\u6700\u4f73\uff08Best-in-Class\uff09\u6f5c\u529b \u4e0a\u6d772025\u5e747\u67083\u65e5 \/\u7f8e\u901a\u793e\/ — \u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u5ba3\u5e03\uff0c\u8212\u6c83\u54f2\u00ae\uff08ZEGFROVY\u00ae\uff0c\u901a\u7528\u540d\uff1a\u8212\u6c83\u66ff\u5c3c\u7247\uff09\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Application\uff0cNDA\uff09\uff0c\u6b63\u5f0f\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\uff0c\u7528\u4e8e\u65e2\u5f80\u7ecf\u542b\u94c2\u5316\u7597\u6cbb\u7597\u65f6\u6216\u6cbb\u7597\u540e\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u5e76\u4e14\u7ecfFDA\u6279\u51c6\u7684\u8bd5\u5242\u76d2\u68c0\u6d4b\u786e\u8ba4\uff0c\u5b58\u5728\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u7684\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u7684\u6210\u4eba\u60a3\u8005\u3002 \u8212\u6c83\u54f2\u00ae\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\u83b7\u5f97\u6279\u51c6\u4e0a\u5e02\uff0c\u6210\u4e3a\u76ee\u524d\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins NSCLC\u56fd\u521b\u65b0\u836f\u3002\u5176\u5728\u5206\u5b50\u8bbe\u8ba1\u7684\u6e90\u5934\u8fdb\u884c\u4e86\u91cd\u5927\u521b\u65b0\uff0c\u7a81\u7834\u96be\u6cbb\u9776\u70b9\uff0c\u662f\u4e2d\u56fd\u9996\u4e2a\u72ec\u7acb\u7814\u53d1\u5728\u7f8e\u83b7\u6279\u7684\u5168\u7403\u9996\u521b\u65b0\u836f\u3002 \u8fea\u54f2\u533b\u836f\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5f20\u5c0f\u6797\u535a\u58eb\u8868\u793a\uff1a”\u4f5c\u4e3a\u516c\u53f8\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684\u521b\u65b0\u836f\uff0c\u8212\u6c83\u54f2\u00ae\u7684\u52a0\u901f\u83b7\u6279\u4e0d\u4ec5\u4e3a\u5168\u7403EGFR 20\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u5e26\u6765\u5168\u65b0\u6cbb\u7597\u65b9\u6848\uff0c\u66f4\u4ee5\u4e2d\u56fd\u6e90\u5934\u521b\u65b0\u8fc8\u51fa\u2018\u79d1\u6280\u521b\u65b0\u5f15\u9886\u5168\u7403’\u5f81\u7a0b\u4e0a\u7684\u65b0\u8de8\u8d8a\u3002\u8212\u6c83\u54f2\u00ae\u662f\u76ee\u524d\u5168\u7403\u552f\u4e00\u83b7\u6279\u6cbb\u7597EGFR exon20ins NSCLC\u7684\u53e3\u670d\u5c0f\u5206\u5b50\u9776\u5411\u836f\uff0c\u5177\u5907\u7597\u6548\u3001\u5b89\u5168\u6027\u53ca\u4fbf\u5229\u6027\u5168\u7403\u540c\u7c7b\u6700\u4f73\u7684\u6f5c\u5728\u4f18\u52bf\u3002\u8fd9\u4e00\u5728\u7f8e\u83b7\u6279\u7684\u91cc\u7a0b\u7891\u4e8b\u4ef6\uff0c\u8fdb\u4e00\u6b65\u575a\u5b9a\u4e86\u8fea\u54f2\u533b\u836f\u81f4\u529b\u4e8e\u4ee5\u7a81\u7834\u6027\u521b\u65b0\u7597\u6cd5\u586b\u8865\u5168\u7403\u672a\u88ab\u6ee1\u8db3\u4e34\u5e8a\u9700\u6c42\u7684\u6218\u7565\u51b3\u5fc3\u3002” \u8212\u6c83\u54f2\u00ae\u662f\u4e00\u6b3e\u53e3\u670d\u3001\u4e0d\u53ef\u9006\u4e14\u9488\u5bf9\u591a\u79cdEGFR\u7a81\u53d8\u4e9a\u578b\u7684\u9ad8\u9009\u62e9\u6027EGFR\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\uff0c\u4e8e2023\u5e748\u6708\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\uff0c\u586b\u8865\u4e86\u8be5\u9886\u57df\u8fd120\u5e74\u4e34\u5e8a\u7a7a\u767d\uff0c\u5e76\u5728\u83b7\u6279\u540e\u7684\u9996\u4e2a\u533b\u4fdd\u5e74\u5ea6\u5373\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u76ee\u5f55\uff0c\u6210\u4e3a\u76ee\u524d\u552f\u4e00\u83b7\u6279\u4e14\u53ef\u533b\u4fdd\u62a5\u9500\u7684EGFR exon20ins NSCLC\u4e8c\/\u540e\u7ebf\u6807\u51c6\u6cbb\u7597\u65b9\u6848\uff0c\u83b7\u4e2d\u56fd\u5404\u5927\u6743\u5a01\u6307\u5357\u6700\u9ad8\u7b49\u7ea7\u63a8\u8350\u3002\u57fa\u4e8e\u4f18\u5f02\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\uff0c\u8212\u6c83\u54f2\u00ae\u662f\u5f53\u524dEGFR exon20ins NSCLC\u6cbb\u7597\u9886\u57df\u5168\u7403\u552f\u4e00\u5168\u7ebf\u62e5\u6709\u4e2d\u3001\u7f8e”\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a”\uff08Breakthrough Therapy Designation\uff0cBTD\uff09”\u5927\u6ee1\u8d2f”\u7684\u836f\u7269\uff0c\u5e76\u5728\u7f8e\u56fd\u9012\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Application\uff0cNDA\uff09\u540e\u88abFDA\u6388\u4e88\u4f18\u5148\u5ba1\u8bc4\uff08Priority Review\uff09\u8d44\u683c\u3002 \u6b64\u6b21\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u83b7FDA\u6279\u51c6\uff0c\u662f\u57fa\u4e8e\u8212\u6c83\u54f2\u00ae\u5728\u56fd\u9645\u591a\u4e2d\u5fc3\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76”\u609f\u7a7a1B”\uff08WU-KONG1B\uff09\u4e2d\uff0c\u9488\u5bf9\u7ecf\u6cbbEGFR exon20ins NSCLC\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u6570\u636e\u3002\u8be5\u9879\u7814\u7a76\u6210\u679c\u57282024\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u4f1a\u4ee5\u53e3\u5934\u62a5\u544a\u5f62\u5f0f\u516c\u5e03\uff0c\u5e76\u4e8e\u8fd1\u65e5\u5168\u6587\u53d1\u8868\u4e8e\u56fd\u9645\u9876\u7ea7\u6742\u5fd7\u300a\u4e34\u5e8a\u80bf\u7624\u5b66\u671f\u520a\u300b\uff08Journal of Clinical Oncology\uff0c\u5f71\u54cd\u56e0\u5b50\uff1a42.1\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u8fdb\u4e00\u6b65\u5728\u5168\u7403\u8303\u56f4\u5185\u8bc1\u660e\u4e86\u8212\u6c83\u54f2\u00ae”\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\u3001\u6f5c\u5728\u540c\u7c7b\u6700\u4f73”\u3002 “\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001\u7f8e\u56fd\u54c8\u4f5b\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u4e39\u5a1c\u6cd5\u4f2f\u764c\u75c7\u7814\u7a76\u9662\uff08Dana-Farber Cancer Institute\uff09Pasi A. J\u00e4nne\u6559\u6388\u8868\u793a\uff1a”\u4f5c\u4e3a\u5168\u7403\u552f\u4e00\u83b7\u6279\u7684EGFR exon20ins NSCLC\u9776\u5411\u53e3\u670d\u7597\u6cd5\uff0c\u8212\u6c83\u66ff\u5c3c\u7684\u4e34\u5e8a\u6570\u636e\u91cd\u5851\u4e86\u8fd9\u4e00\u9886\u57df\u957f\u671f\u7f3a\u4e4f\u65b9\u4fbf\u6709\u6548\u6cbb\u7597\u624b\u6bb5\u7684\u5386\u53f2\u3002WU-KONG1B\u7684\u6570\u636e\u8bc1\u5b9e\uff0c\u8212\u6c83\u66ff\u5c3c\u5c55\u73b0\u51fa\u663e\u8457\u7684\u7597\u6548\u4f18\u52bf\uff0c\u4e14\u5728\u975e\u4e9a\u88d4\u60a3\u8005\u7fa4\u4f53\u4e2d\u5f97\u5230\u540c\u6837\u9a8c\u8bc1\u3002\u6b64\u5916\uff0c\u5176\u6bcf\u65e5\u4e00\u6b21\u7684\u53e3\u670d\u7ed9\u836f\u65b9\u5f0f\u6781\u5927\u7684\u63d0\u5347\u4e86\u6cbb\u7597\u4fbf\u5229\u6027\u548c\u60a3\u8005\u4f9d\u4ece\u6027\uff0c\u8fd9\u5728\u80ba\u764c\u6162\u75c5\u5316\u7ba1\u7406\u8d8b\u52bf\u4e2d\u5177\u6709\u81f3\u5173\u91cd\u8981\u7684\u4e34\u5e8a\u4ef7\u503c\u3002\u8212\u6c83\u66ff\u5c3c\u5728\u7f8e\u83b7\u6279\u4ee3\u8868\u7740\u79d1\u5b66\u521b\u65b0\u7684\u91cd\u8981\u7a81\u7834\uff0c\u66f4\u662f\u5bf9\u5168\u7403\u60a3\u8005\u957f\u671f\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u7684\u91cc\u7a0b\u7891\u5f0f\u56de\u5e94\u3002” “\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u53e6\u4e00\u4f4d\u4e3b\u8981\u7814\u7a76\u8005\u3001\u53f0\u6e7e\u5927\u5b66\u764c\u533b\u4e2d\u5fc3\u5206\u9662\u6768\u5fd7\u65b0\u6559\u6388\u8868\u793a\uff1a\u201c\u4f5c\u4e3a\u6b64\u9879\u7814\u7a76\u7684\u6df1\u5ea6\u53c2\u4e0e\u8005\uff0c\u6211\u4eec\u901a\u8fc7\u4e25\u8c28\u7684\u8de8\u56fd\u4e34\u5e8a\u8bd5\u9a8c\u8bc1\u5b9e\u4e86\u8212\u6c83\u66ff\u5c3c\u5728EGFR exon20ins NSCLC\u6cbb\u7597\u7684\u7a81\u7834\u6027\u4ef7\u503c\uff0c\u8fd9\u79cd\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\u4e14\u53e3\u670d\u4fbf\u5229\u7684\u7279\u6027\uff0c\u4f7f\u5176\u6210\u4e3a\u4e34\u5e8a\u5b9e\u8df5\u4e2d\u7684\u7406\u60f3\u9009\u62e9\uff0c\u6253\u7834\u4e86\u957f\u671f\u4ee5\u6765EGFR exon20ins\u7f3a\u4e4f\u517c\u5177\u2018\u7597\u6548\u3001\u5b89\u5168\u6027\u3001\u4fbf\u5229\u6027\u2019\u5c0f\u5206\u5b50\u53e3\u670d\u9776\u5411\u836f\u7269\u6cbb\u7597\u7684\u50f5\u5c40\u3002\u8212\u6c83\u66ff\u5c3c\u5728\u5168\u7403\u4e3b\u8981\u5e02\u573a\u7684\u4e0a\u5e02\uff0c\u4e0d\u4ec5\u70b9\u71c3\u4e86\u60a3\u8005\u7684\u5e0c\u671b\uff0c\u66f4\u575a\u5b9a\u4e86\u6211\u4eec\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\uff0c\u6301\u7eed\u63a8\u8fdb\u80ba\u764c\u7cbe\u51c6\u6cbb\u7597\u4e0d\u65ad\u5411\u524d\u7684\u4fe1\u5ff5\u3002\u201d \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u8212\u6c83\u54f2\u00ae\u4e2d\u56fd\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\uff08\u609f\u7a7a6\uff0cWU-KONG6\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001”\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001\u5317\u4eac\u534f\u548c\u533b\u9662\u738b\u5b5f\u662d\u6559\u6388\u8868\u793a\uff1a”EGFR exon20ins \u662fEGFR\u7684\u7b2c\u4e09\u5927\u539f\u53d1\u7a81\u53d8\uff0c\u56e0\u5176\u72ec\u7279\u7684\u7a7a\u95f4\u6784\u8c61\uff0c\u4f20\u7edf\u7684EGFR TKI\u96be\u4ee5\u4e0e\u8be5\u9776\u70b9\u7ed3\u5408\uff0c\u60a3\u8005\u6cbb\u7597\u9009\u62e9\u6709\u9650\uff0c\u9884\u540e\u8f83\u5dee\uff0c\u4e00\u76f4\u4ee5\u6765\u662f\u5168\u7403\u80ba\u764c\u65b0\u836f\u7814\u53d1\u4e2d\u6781\u5177\u6311\u6218\u6027\u7684\u96be\u9898\u3002\u2018\u609f\u7a7a6’\uff08WU-KONG6\uff09\u7814\u7a76\u6210\u679c\u9a8c\u8bc1\u4e86\u8212\u6c83\u66ff\u5c3c\u7a81\u7834EGFR exon20ins NSCLC\u6cbb\u7597\u74f6\u9888\uff0c\u63a8\u52a8\u4e86\u5176\u5728\u56fd\u5185\u83b7\u6279\u4e0a\u5e02\uff0c\u4f7f\u5f97\u4e2d\u56fd\u60a3\u8005\u80fd\u7387\u5148\u53d7\u76ca\u4e8e\u5177\u6709\u56fd\u9645\u9886\u5148\u6c34\u5e73\u7684\u521b\u65b0\u7597\u6cd5\u3002\u5982\u4eca\uff0c\u8212\u6c83\u66ff\u5c3c\u5728\u7f8e\u56fd\u6210\u529f\u83b7\u6279\uff0c\u4f5c\u4e3a\u7814\u7a76\u8005\uff0c\u4e3a\u6765\u81ea\u4e2d\u56fd\u7684\u6e90\u5934\u521b\u65b0\u6210\u679c\u8d70\u5411\u4e16\u754c\uff0c\u8fdb\u4e00\u6b65\u60e0\u53ca\u5168\u7403\u60a3\u8005\u800c\u6df1\u611f\u81ea\u8c6a\u3002” […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/moneycompass.com.my\/cn\/\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u83b7fda\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\/\" \/>\n<meta property=\"og:site_name\" content=\"Money Compass CN\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-03T00:06:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/07\/1-A60nRj.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"144\" \/>\n\t<meta property=\"og:image:height\" content=\"81\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/\",\"name\":\"\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f - Money Compass CN\",\"isPartOf\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/07\/1-A60nRj.jpeg\",\"datePublished\":\"2025-07-03T00:06:00+00:00\",\"dateModified\":\"2025-07-03T00:06:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#primaryimage\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/07\/1-A60nRj.jpeg\",\"contentUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/07\/1-A60nRj.jpeg\",\"width\":144,\"height\":81},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/moneycompass.com.my\/cn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/\",\"name\":\"Money Compass CN\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f - Money Compass CN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/moneycompass.com.my\/cn\/\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u83b7fda\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\/","og_locale":"en_US","og_type":"article","og_title":"\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f - Money Compass CN","og_description":"\u8212\u6c83\u54f2\u00ae\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\uff0c\u6210\u4e3a\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u5728\u7f8e\u56fd\u83b7\u6279\u7684\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u56fd\u521b\u65b0\u836f\uff0c\u540c\u65f6\u4e5f\u662f\u4e2d\u56fd\u9996\u4e2a\u72ec\u7acb\u7814\u53d1\u5728\u7f8e\u83b7\u6279\u7684\u5168\u7403\u9996\u521b\u65b0\u836f\u6b64\u6b21\u52a0\u901f\u6279\u51c6\u57fa\u4e8e\u56fd\u9645\u591a\u4e2d\u5fc3\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\uff08\u609f\u7a7a1B,WU-KONG1B\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u5c55\u73b0\u8212\u6c83\u54f2\u00ae\u9488\u5bf9\u7ecf\u6cbbEGFR exon20ins NSCLC\u5168\u7403\u540c\u7c7b\u6700\u4f73\uff08Best-in-Class\uff09\u6f5c\u529b \u4e0a\u6d772025\u5e747\u67083\u65e5 \/\u7f8e\u901a\u793e\/ — \u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u5ba3\u5e03\uff0c\u8212\u6c83\u54f2\u00ae\uff08ZEGFROVY\u00ae\uff0c\u901a\u7528\u540d\uff1a\u8212\u6c83\u66ff\u5c3c\u7247\uff09\u7684\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Application\uff0cNDA\uff09\uff0c\u6b63\u5f0f\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\uff0c\u7528\u4e8e\u65e2\u5f80\u7ecf\u542b\u94c2\u5316\u7597\u6cbb\u7597\u65f6\u6216\u6cbb\u7597\u540e\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u5e76\u4e14\u7ecfFDA\u6279\u51c6\u7684\u8bd5\u5242\u76d2\u68c0\u6d4b\u786e\u8ba4\uff0c\u5b58\u5728\u8868\u76ae\u751f\u957f\u56e0\u5b50\u53d7\u4f53\uff08EGFR\uff0920\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u7684\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u7684\u6210\u4eba\u60a3\u8005\u3002 \u8212\u6c83\u54f2\u00ae\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u7a0b\u5e8f\u83b7\u5f97\u6279\u51c6\u4e0a\u5e02\uff0c\u6210\u4e3a\u76ee\u524d\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins NSCLC\u56fd\u521b\u65b0\u836f\u3002\u5176\u5728\u5206\u5b50\u8bbe\u8ba1\u7684\u6e90\u5934\u8fdb\u884c\u4e86\u91cd\u5927\u521b\u65b0\uff0c\u7a81\u7834\u96be\u6cbb\u9776\u70b9\uff0c\u662f\u4e2d\u56fd\u9996\u4e2a\u72ec\u7acb\u7814\u53d1\u5728\u7f8e\u83b7\u6279\u7684\u5168\u7403\u9996\u521b\u65b0\u836f\u3002 \u8fea\u54f2\u533b\u836f\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5f20\u5c0f\u6797\u535a\u58eb\u8868\u793a\uff1a”\u4f5c\u4e3a\u516c\u53f8\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684\u521b\u65b0\u836f\uff0c\u8212\u6c83\u54f2\u00ae\u7684\u52a0\u901f\u83b7\u6279\u4e0d\u4ec5\u4e3a\u5168\u7403EGFR 20\u53f7\u5916\u663e\u5b50\u63d2\u5165\u7a81\u53d8\uff08exon20ins\uff09\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u60a3\u8005\u5e26\u6765\u5168\u65b0\u6cbb\u7597\u65b9\u6848\uff0c\u66f4\u4ee5\u4e2d\u56fd\u6e90\u5934\u521b\u65b0\u8fc8\u51fa\u2018\u79d1\u6280\u521b\u65b0\u5f15\u9886\u5168\u7403’\u5f81\u7a0b\u4e0a\u7684\u65b0\u8de8\u8d8a\u3002\u8212\u6c83\u54f2\u00ae\u662f\u76ee\u524d\u5168\u7403\u552f\u4e00\u83b7\u6279\u6cbb\u7597EGFR exon20ins NSCLC\u7684\u53e3\u670d\u5c0f\u5206\u5b50\u9776\u5411\u836f\uff0c\u5177\u5907\u7597\u6548\u3001\u5b89\u5168\u6027\u53ca\u4fbf\u5229\u6027\u5168\u7403\u540c\u7c7b\u6700\u4f73\u7684\u6f5c\u5728\u4f18\u52bf\u3002\u8fd9\u4e00\u5728\u7f8e\u83b7\u6279\u7684\u91cc\u7a0b\u7891\u4e8b\u4ef6\uff0c\u8fdb\u4e00\u6b65\u575a\u5b9a\u4e86\u8fea\u54f2\u533b\u836f\u81f4\u529b\u4e8e\u4ee5\u7a81\u7834\u6027\u521b\u65b0\u7597\u6cd5\u586b\u8865\u5168\u7403\u672a\u88ab\u6ee1\u8db3\u4e34\u5e8a\u9700\u6c42\u7684\u6218\u7565\u51b3\u5fc3\u3002” \u8212\u6c83\u54f2\u00ae\u662f\u4e00\u6b3e\u53e3\u670d\u3001\u4e0d\u53ef\u9006\u4e14\u9488\u5bf9\u591a\u79cdEGFR\u7a81\u53d8\u4e9a\u578b\u7684\u9ad8\u9009\u62e9\u6027EGFR\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08TKI\uff09\uff0c\u4e8e2023\u5e748\u6708\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\uff0c\u586b\u8865\u4e86\u8be5\u9886\u57df\u8fd120\u5e74\u4e34\u5e8a\u7a7a\u767d\uff0c\u5e76\u5728\u83b7\u6279\u540e\u7684\u9996\u4e2a\u533b\u4fdd\u5e74\u5ea6\u5373\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u76ee\u5f55\uff0c\u6210\u4e3a\u76ee\u524d\u552f\u4e00\u83b7\u6279\u4e14\u53ef\u533b\u4fdd\u62a5\u9500\u7684EGFR exon20ins NSCLC\u4e8c\/\u540e\u7ebf\u6807\u51c6\u6cbb\u7597\u65b9\u6848\uff0c\u83b7\u4e2d\u56fd\u5404\u5927\u6743\u5a01\u6307\u5357\u6700\u9ad8\u7b49\u7ea7\u63a8\u8350\u3002\u57fa\u4e8e\u4f18\u5f02\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\uff0c\u8212\u6c83\u54f2\u00ae\u662f\u5f53\u524dEGFR exon20ins NSCLC\u6cbb\u7597\u9886\u57df\u5168\u7403\u552f\u4e00\u5168\u7ebf\u62e5\u6709\u4e2d\u3001\u7f8e”\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a”\uff08Breakthrough Therapy Designation\uff0cBTD\uff09”\u5927\u6ee1\u8d2f”\u7684\u836f\u7269\uff0c\u5e76\u5728\u7f8e\u56fd\u9012\u4ea4\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Application\uff0cNDA\uff09\u540e\u88abFDA\u6388\u4e88\u4f18\u5148\u5ba1\u8bc4\uff08Priority Review\uff09\u8d44\u683c\u3002 \u6b64\u6b21\u901a\u8fc7\u4f18\u5148\u5ba1\u8bc4\u83b7FDA\u6279\u51c6\uff0c\u662f\u57fa\u4e8e\u8212\u6c83\u54f2\u00ae\u5728\u56fd\u9645\u591a\u4e2d\u5fc3\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76”\u609f\u7a7a1B”\uff08WU-KONG1B\uff09\u4e2d\uff0c\u9488\u5bf9\u7ecf\u6cbbEGFR exon20ins NSCLC\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u6570\u636e\u3002\u8be5\u9879\u7814\u7a76\u6210\u679c\u57282024\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u4f1a\u4ee5\u53e3\u5934\u62a5\u544a\u5f62\u5f0f\u516c\u5e03\uff0c\u5e76\u4e8e\u8fd1\u65e5\u5168\u6587\u53d1\u8868\u4e8e\u56fd\u9645\u9876\u7ea7\u6742\u5fd7\u300a\u4e34\u5e8a\u80bf\u7624\u5b66\u671f\u520a\u300b\uff08Journal of Clinical Oncology\uff0c\u5f71\u54cd\u56e0\u5b50\uff1a42.1\uff09\uff0c\u7814\u7a76\u7ed3\u679c\u8fdb\u4e00\u6b65\u5728\u5168\u7403\u8303\u56f4\u5185\u8bc1\u660e\u4e86\u8212\u6c83\u54f2\u00ae”\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\u3001\u6f5c\u5728\u540c\u7c7b\u6700\u4f73”\u3002 “\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001\u7f8e\u56fd\u54c8\u4f5b\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u4e39\u5a1c\u6cd5\u4f2f\u764c\u75c7\u7814\u7a76\u9662\uff08Dana-Farber Cancer Institute\uff09Pasi A. J\u00e4nne\u6559\u6388\u8868\u793a\uff1a”\u4f5c\u4e3a\u5168\u7403\u552f\u4e00\u83b7\u6279\u7684EGFR exon20ins NSCLC\u9776\u5411\u53e3\u670d\u7597\u6cd5\uff0c\u8212\u6c83\u66ff\u5c3c\u7684\u4e34\u5e8a\u6570\u636e\u91cd\u5851\u4e86\u8fd9\u4e00\u9886\u57df\u957f\u671f\u7f3a\u4e4f\u65b9\u4fbf\u6709\u6548\u6cbb\u7597\u624b\u6bb5\u7684\u5386\u53f2\u3002WU-KONG1B\u7684\u6570\u636e\u8bc1\u5b9e\uff0c\u8212\u6c83\u66ff\u5c3c\u5c55\u73b0\u51fa\u663e\u8457\u7684\u7597\u6548\u4f18\u52bf\uff0c\u4e14\u5728\u975e\u4e9a\u88d4\u60a3\u8005\u7fa4\u4f53\u4e2d\u5f97\u5230\u540c\u6837\u9a8c\u8bc1\u3002\u6b64\u5916\uff0c\u5176\u6bcf\u65e5\u4e00\u6b21\u7684\u53e3\u670d\u7ed9\u836f\u65b9\u5f0f\u6781\u5927\u7684\u63d0\u5347\u4e86\u6cbb\u7597\u4fbf\u5229\u6027\u548c\u60a3\u8005\u4f9d\u4ece\u6027\uff0c\u8fd9\u5728\u80ba\u764c\u6162\u75c5\u5316\u7ba1\u7406\u8d8b\u52bf\u4e2d\u5177\u6709\u81f3\u5173\u91cd\u8981\u7684\u4e34\u5e8a\u4ef7\u503c\u3002\u8212\u6c83\u66ff\u5c3c\u5728\u7f8e\u83b7\u6279\u4ee3\u8868\u7740\u79d1\u5b66\u521b\u65b0\u7684\u91cd\u8981\u7a81\u7834\uff0c\u66f4\u662f\u5bf9\u5168\u7403\u60a3\u8005\u957f\u671f\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u7684\u91cc\u7a0b\u7891\u5f0f\u56de\u5e94\u3002” “\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u53e6\u4e00\u4f4d\u4e3b\u8981\u7814\u7a76\u8005\u3001\u53f0\u6e7e\u5927\u5b66\u764c\u533b\u4e2d\u5fc3\u5206\u9662\u6768\u5fd7\u65b0\u6559\u6388\u8868\u793a\uff1a\u201c\u4f5c\u4e3a\u6b64\u9879\u7814\u7a76\u7684\u6df1\u5ea6\u53c2\u4e0e\u8005\uff0c\u6211\u4eec\u901a\u8fc7\u4e25\u8c28\u7684\u8de8\u56fd\u4e34\u5e8a\u8bd5\u9a8c\u8bc1\u5b9e\u4e86\u8212\u6c83\u66ff\u5c3c\u5728EGFR exon20ins NSCLC\u6cbb\u7597\u7684\u7a81\u7834\u6027\u4ef7\u503c\uff0c\u8fd9\u79cd\u5f3a\u6548\u7f29\u7624\u3001\u5b89\u5168\u53ef\u63a7\u4e14\u53e3\u670d\u4fbf\u5229\u7684\u7279\u6027\uff0c\u4f7f\u5176\u6210\u4e3a\u4e34\u5e8a\u5b9e\u8df5\u4e2d\u7684\u7406\u60f3\u9009\u62e9\uff0c\u6253\u7834\u4e86\u957f\u671f\u4ee5\u6765EGFR exon20ins\u7f3a\u4e4f\u517c\u5177\u2018\u7597\u6548\u3001\u5b89\u5168\u6027\u3001\u4fbf\u5229\u6027\u2019\u5c0f\u5206\u5b50\u53e3\u670d\u9776\u5411\u836f\u7269\u6cbb\u7597\u7684\u50f5\u5c40\u3002\u8212\u6c83\u66ff\u5c3c\u5728\u5168\u7403\u4e3b\u8981\u5e02\u573a\u7684\u4e0a\u5e02\uff0c\u4e0d\u4ec5\u70b9\u71c3\u4e86\u60a3\u8005\u7684\u5e0c\u671b\uff0c\u66f4\u575a\u5b9a\u4e86\u6211\u4eec\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3\uff0c\u6301\u7eed\u63a8\u8fdb\u80ba\u764c\u7cbe\u51c6\u6cbb\u7597\u4e0d\u65ad\u5411\u524d\u7684\u4fe1\u5ff5\u3002\u201d \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u8212\u6c83\u54f2\u00ae\u4e2d\u56fd\u6ce8\u518c\u4e34\u5e8a\u7814\u7a76\uff08\u609f\u7a7a6\uff0cWU-KONG6\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001”\u609f\u7a7a1B“\uff08WU-KONG1B\uff09\u4e3b\u8981\u7814\u7a76\u8005\u3001\u5317\u4eac\u534f\u548c\u533b\u9662\u738b\u5b5f\u662d\u6559\u6388\u8868\u793a\uff1a”EGFR exon20ins \u662fEGFR\u7684\u7b2c\u4e09\u5927\u539f\u53d1\u7a81\u53d8\uff0c\u56e0\u5176\u72ec\u7279\u7684\u7a7a\u95f4\u6784\u8c61\uff0c\u4f20\u7edf\u7684EGFR TKI\u96be\u4ee5\u4e0e\u8be5\u9776\u70b9\u7ed3\u5408\uff0c\u60a3\u8005\u6cbb\u7597\u9009\u62e9\u6709\u9650\uff0c\u9884\u540e\u8f83\u5dee\uff0c\u4e00\u76f4\u4ee5\u6765\u662f\u5168\u7403\u80ba\u764c\u65b0\u836f\u7814\u53d1\u4e2d\u6781\u5177\u6311\u6218\u6027\u7684\u96be\u9898\u3002\u2018\u609f\u7a7a6’\uff08WU-KONG6\uff09\u7814\u7a76\u6210\u679c\u9a8c\u8bc1\u4e86\u8212\u6c83\u66ff\u5c3c\u7a81\u7834EGFR exon20ins NSCLC\u6cbb\u7597\u74f6\u9888\uff0c\u63a8\u52a8\u4e86\u5176\u5728\u56fd\u5185\u83b7\u6279\u4e0a\u5e02\uff0c\u4f7f\u5f97\u4e2d\u56fd\u60a3\u8005\u80fd\u7387\u5148\u53d7\u76ca\u4e8e\u5177\u6709\u56fd\u9645\u9886\u5148\u6c34\u5e73\u7684\u521b\u65b0\u7597\u6cd5\u3002\u5982\u4eca\uff0c\u8212\u6c83\u66ff\u5c3c\u5728\u7f8e\u56fd\u6210\u529f\u83b7\u6279\uff0c\u4f5c\u4e3a\u7814\u7a76\u8005\uff0c\u4e3a\u6765\u81ea\u4e2d\u56fd\u7684\u6e90\u5934\u521b\u65b0\u6210\u679c\u8d70\u5411\u4e16\u754c\uff0c\u8fdb\u4e00\u6b65\u60e0\u53ca\u5168\u7403\u60a3\u8005\u800c\u6df1\u611f\u81ea\u8c6a\u3002” […]","og_url":"https:\/\/moneycompass.com.my\/cn\/\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u83b7fda\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\/","og_site_name":"Money Compass CN","article_published_time":"2025-07-03T00:06:00+00:00","og_image":[{"width":144,"height":81,"url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/07\/1-A60nRj.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/","url":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/","name":"\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f - Money Compass CN","isPartOf":{"@id":"https:\/\/moneycompass.com.my\/cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#primaryimage"},"image":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#primaryimage"},"thumbnailUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/07\/1-A60nRj.jpeg","datePublished":"2025-07-03T00:06:00+00:00","dateModified":"2025-07-03T00:06:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#primaryimage","url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/07\/1-A60nRj.jpeg","contentUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/07\/1-A60nRj.jpeg","width":144,"height":81},{"@type":"BreadcrumbList","@id":"https:\/\/moneycompass.com.my\/cn\/%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%88%92%e6%b2%83%e5%93%b2%e8%8e%b7fda%e5%8a%a0%e9%80%9f%e6%89%b9%e5%87%86%e4%b8%8a%e5%b8%82%ef%bc%8c%e7%b3%bb%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9c%a8\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/moneycompass.com.my\/cn\/"},{"@type":"ListItem","position":2,"name":"\u8fea\u54f2\u533b\u836f\u8212\u6c83\u54f2\u00ae\u83b7FDA\u52a0\u901f\u6279\u51c6\u4e0a\u5e02\uff0c\u7cfb\u5168\u7403\u9996\u6b3e\u5728\u7f8e\u83b7\u6279\u7684EGFR exon20ins\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u56fd\u521b\u65b0\u836f"}]},{"@type":"WebSite","@id":"https:\/\/moneycompass.com.my\/cn\/#website","url":"https:\/\/moneycompass.com.my\/cn\/","name":"Money Compass CN","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/13251"}],"collection":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/comments?post=13251"}],"version-history":[{"count":0,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/13251\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media\/13252"}],"wp:attachment":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media?parent=13251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/categories?post=13251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/tags?post=13251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}